The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Silybin and silymarin - new effects and applications
Open accessAbstract
This article aims to review critically literature published mainly within this millennium on the new and emerging applications of silymarin, the polyphenolic fraction from the seeds of Silybum marianum and its main component silybin. Silymarin and silybin used so far mostly as hepatoprotectants were shown to have other interesting activities as e.g., anticancer and canceroprotective. These activities were demonstrated in a large variety of illnesses of different organs as e.g., prostate, lungs, CNS, kidneys, pancreas and others. Besides the cytoprotective activity of silybin mediated by its antioxidative and radical-scavenging properties also new activities based on the specific receptor interaction were discovered--e.g., inhibition and modulation of drug transporters, P-glycoproteins, estrogenic receptors, nuclear receptors and some others. New derivatives of silybin open new ways to its therapeutic applications. Pharmacology dealing with optically pure silybin diastereomers may suggest new mechanisms of its action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
International Journal of Molecular Medicine
(2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm · Cited by 2,246
The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines
Marty, A. T. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.281.19.1852 · Cited by 846
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Mueller, S. O. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh147 · Cited by 547
Role of chemopreventive agents in cancer therapy
Dorai, T., & Aggarwal, B. B. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.013 · Cited by 529
Natural phenolics in the prevention of UV-induced skin damage. A review
Svobodová, A., Psotová, J., & Walterová, D. (2003) · Biomedical Papers · doi:10.5507/bp.2003.019 · Cited by 455
Self-citationFraschini, F., Demartini, G., & Esposti, D. (2002) · Clinical Drug Investigation · doi:10.2165/00044011-200222010-00007 · Cited by 380
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375
Protective effects of silymarin against photocarcinogenesis in a mouse skin model
Katiyar, S. K., Korman, N. J., Mukhtar, H., & Agarwal, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.8.556 · Cited by 355
Tissue injury by reactive oxygen species and the protective effects of flavonoids
de Groot, H., & Rauen, U. (1998) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00951.x · Cited by 330
Tyagi, A. K., Singh, R. P., Agarwal, C., Chan, D. C. F., & Agarwal, R. (2002) · PubMed · Cited by 323
Zhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
Silybum marianum (Carduus marianus)
Morazzoni, P., & Bombardelli, E. (1995) · Fitoterapia · Cited by 299
Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · PubMed · Cited by 293
Kim, N.-C., Graf, T. N., Sparacino, C. M., Wani, M. C., & Wall, M. E. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b300099k · Cited by 278
Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6800 · Cited by 273
Milk thistle for the treatment of liver disease
Jacobs, B. P., Dennehy, C., Ramirez, G., Sapp, J., & Lawrence, V. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01244-5 · Cited by 247
Lee, D. Y.-W., & Liu (2003) · Journal of Natural Products · doi:10.1021/np030163b · Cited by 242
Zi, X., & Agarwal, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7490 · Cited by 235
Leslie, E. M., Mao, Q., Oleschuk, C. J., Deeley, R. G., & Cole, S. P. C. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1171 · Cited by 231
Agarwal, C., Singh, R. P., Dhanalakshmi, S., Tyagi, A. K., Tecklenburg, M., Sclafani, R. A., & Agarwal, R. (2003) · Oncogene · doi:10.1038/sj.onc.1207158 · Cited by 226
Wang, M., Lin, W., Chen, H., Chang, Y., Ou, H., Kuo, J., Hong, J., & Jeng, K. G. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02290.x · Cited by 213
Lahiri-Chatterjee, M., Katiyar, S. K., Mohan, R. R., & Agarwal, R. (1999) · PubMed · Cited by 208
Katiyar, S. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.1.169 · Cited by 200
Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas
Soto, C., Recoba, R., Barrón, H., Alvarez, C., & Favari, L. (2003) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00214-x · Cited by 188
Schroeter, H., Williams, R. J., Matin, R., Iversen, L., & Rice-Evans, C. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00415-9 · Cited by 184
Journal of Pharmaceutical Sciences
(2006) · Journal of Pharmaceutical Sciences · doi:10.1002/(issn)1520-6017 · Cited by 182
Chu, S., Chiou, H., Chen, P., Yang, S., & Hsieh, Y. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20018 · Cited by 176
Zi, X., Feyes, D. K., & Agarwal, R. (1998) · PubMed · Cited by 164
Tyagi, A., Agarwal, C., Chan, D., & Agarwal, R. (2004) · Oncology Reports · doi:10.3892/or.11.2.493 · Cited by 158
Han, D.-H., Denison, M. S., Tachibana, H., & Yamada, K. (2002) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.66.1479 · Cited by 157
Oxidised derivatives of silybin and their antiradical and antioxidant activity
Gažák, R., Svobodová, A. R., Psotová, J., Sedmera, P., Přikrylová, V., Daniela Walterová, B., & Křen, V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.064 · Cited by 156
Self-citationGuz, N. R., Stermitz, F. R., Johnson, J. B., Beeson, T. D., Willen, S., Hsiang, J.-F., & Lewis, K. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0004190 · Cited by 155
Dhanalakshmi, S., Singh, R. P., Agarwal, C., & Agarwal, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205240 · Cited by 154
Singh, R. P., Tyagi, A. K., Zhao, J., & Agarwal, R. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.499 · Cited by 150
Kohno, H., Tanaka, T., Kawabata, K., Hirose, Y., Sugie, S., Tsuda, H., & Mori, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10625 · Cited by 149
Gu, M., Dhanalakshmi, S., Singh, R. P., Agarwal, C., & Agarwal, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1632 · Cited by 149
Rastogi, R. P., Srivastava, A. K., & Rastogi, A. K. (2001) · Phytotherapy Research · doi:10.1002/ptr.722 · Cited by 147
Flavonoid Antioxidant Silymarin and Skin Cancer
Singh, R. P., & Agarwal, R. (2002) · Antioxidants and Redox Signaling · doi:10.1089/15230860260220166 · Cited by 140
Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activities
Zuber, R., Modrianský, M., Dvořák, Z., Rohovský, P., Ulrichová, J., Šimánek, V., & Anzenbacher, P. (2002) · Phytotherapy Research · doi:10.1002/ptr.1000 · Cited by 139
Effect of Milk Thistle on the Pharmacokinetics of Indinavir in Healthy Volunteers
Piscitelli, S. C., Formentini, E., Burstein, A. H., Alfaro, R. M., Jagannatha, S., & Falloon, J. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.8.551.33205 · Cited by 138
Inhibitory Effects of Silibinin on Cytochrome P‐450 Enzymes in Human Liver Microsomes
Beckmann‐Knopp, S., Rietbrock, S., Weyhenmeyer, R., Böcker, R. H., Beckurts, K. T. E., Lang, W., Hunz, M., & Fuhr, U. (2000) · Pharmacology & Toxicology · doi:10.1111/j.0901-9928.2000.860602.x · Cited by 136
Singh, R. P., Gu, M., Sharma, G. D., Dhanalakshmi, S., Tyagi, A. K., Chan, D. C. F., Agarwal, C., & Agarwal, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1435 · Cited by 131
Effect of Flavonoids on MRP1-Mediated Transport in Panc-1 Cells
Nguyen, H. T. T., Zhang, S., & Morris, M. E. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10283 · Cited by 131
Jiang, C., Agarwal, R., & Lü, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3474 · Cited by 128
Zi, X., Zhang, J., Agarwal, R., & Pollak, M. (2000) · PubMed · Cited by 126
Zhu, W. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1399 · Cited by 124
Botanical antioxidants for chemoprevention of photocarcinogenesis
Afaq, F., Adhami, V. M., Ahmad, N., & Mukhtar, H. (2002) · Frontiers in bioscience · doi:10.2741/afaq · Cited by 124
Zhao, J., Lahiri-Chatterjee, M., Sharma, Y., & Agarwal, R. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.811 · Cited by 123
Zhang, S., & Morris, M. E. (2003) · Pharmaceutical Research · doi:10.1023/a:1025044913766 · Cited by 120
Prevention of Alloxan-Induced Diabetes Mellitus in the Rat by Silymarin
Soto, C. P., Perez, B. L., Favari, L., & Reyes, J. L. (1998) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(97)00198-9 · Cited by 119
Katiyar, S. K. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.6.1213 · Cited by 118
Silymarin induces recovery of pancreatic function after alloxan damage in rats
Soto, C., Mena, R., Luna, J., Cerbón, M. A., Larrieta, E., Vital, P., Uría-Galicia, E., Sánchez, M., Recoba, R., Barrón, H., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.019 · Cited by 112
Coadministration of Milk Thistle and Indinavir in Healthy Subjects
DiCenzo, R., Shelton, M. J., Jordan, K. H., Koval, C. E., Forrest, A., Reichman, R. C., & Morse, G. D. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.866.32723 · Cited by 110
Ahmad, N., Gali, H. U., Javed, S., & Agarwal, R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8748 · Cited by 108
Zhao, J., Sharma, Y., & Agarwal, R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199912)26:4<321::aid-mc11>3.0.co;2-9 · Cited by 107
Maghrani, M., Zeggwagh, N. A., Lemhadri, A., Amraoui, M. E., Jb, M., & Eddouks, M. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.01.008 · Cited by 105
Scambia, G., Vincenzo, R. D., Ranelletti, P. O., Panici, P. B., Ferrandina, G., D’Agostino, G. R., Fattorossi, A., Bombardelli, E., & Mancuso, S. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00011-1 · Cited by 103
Weyhenmeyer, R., Mascher, H. J., & Birkmayer, J. G. D. (1992) · PubMed · Cited by 99
Silymarin: What is in the name …? An appeal for a change of editorial policy
Šimánek, V., Křen, V., Ulrichová, J., Vičar, J., & Cvak, L. (2000) · Hepatology · doi:10.1053/jhep.2000.9770 · Cited by 99
Self-citationAnti-angiogenic effect of silymarin on colon cancer lovo cell line
Yang, S.-H., Lin, J.-K., Chen, W.-S., & Chiu, J. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00229-4 · Cited by 99
Saliou, C., Rihn, B. H., Cillard, J., Okamoto, T., & Packer, L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01409-4 · Cited by 97
Agarwal, R., Katiyar, S. K., Lundgren, D. W., & Mukhtar, H. (1994) · Carcinogenesis · doi:10.1093/carcin/15.6.1099 · Cited by 97
Rodriguez, R. J., Miranda, C. L., Stevens, J. F., Deinzer, M. L., & Buhler, D. R. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00159-9 · Cited by 94
Seidlová‐Wuttke, D., Becker, T., Christoffel, V., Jarry, H., & Wuttke, W. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00270-x · Cited by 90
Maitrejean, M., Comte, G., Barron, D., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00636-8 · Cited by 90
Antioxidant properties of silybin glycosides
Kosina, P., en, V. K., Gebhardt, R., Grambal, F., Ulrichov�, J., & Walterov�, D. (2002) · Phytotherapy Research · doi:10.1002/ptr.796 · Cited by 89
Self-citationEstrogen Receptor-Mediated Actions of Polyphenolic Catechins in Vivo and in Vitro
Goodin, M. G. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.2.354 · Cited by 89
Matsuda, T., Ferreri, K., Todorov, I., Kuroda, Y., Smith, C. V., KANDEEL, F. R., & Mullen, Y. (2004) · Endocrinology · doi:10.1210/en.2004-0850 · Cited by 87
Plíšková, M., Vondráček, J., Křen, V., Gažák, R., Sedmera, P., Walterová, D., Psotová, J., Šimánek, V., & Machala, M. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.020 · Cited by 81
Self-citationGallo, D., Giacomelli, S., Ferlini, C., Raspaglio, G., Apollonio, P., Prislei, S., Riva, A., Morazzoni, P., Bombardelli, E., & Scambia, G. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00624-5 · Cited by 80
Džubák, P., Hajdúch, M., Gažák, R., Svobodová, A. R., Psotová, J., Walterová, D., Sedmera, P., & Křen, V. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.035 · Cited by 78
Self-citationChlopčíková, Š., Psotová, J., Miketová, P., & Šimánek, V. (2004) · Phytotherapy Research · doi:10.1002/ptr.1415 · Cited by 78
Stermitz, F. R., Beeson, T. D., Mueller, P. J., Hsiang, J.-F., & Lewis, K. (2001) · Biochemical Systematics and Ecology · doi:10.1016/s0305-1978(01)00025-4 · Cited by 72
Dhanalakshmi, S., Gu, M., Singh, R. P., & Agarwal, R. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg188 · Cited by 70
Zi, X., & Agarwal, R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1398 · Cited by 64
Chatterjee, M. L., Agarwal, R., & Mukhtar, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1848 · Cited by 57
Vinh, P. Q., Sugie, S., Tanaka, T., Hara, A., Yamada, Y., Katayama, M., Deguchi, T., & Mori, H. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01199.x · Cited by 55
Ahlenstiel, T., Burkhardt, G., Köhler, H., & Kuhlmann, M. K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00774.x · Cited by 54
Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects.
Mulrow, C. D., Lawrence, V. A., Jacobs, B. P., Dennehy, C. E., Sapp, J., Ramı́rez, G., Aguilar, C., Montgomery, K., Morbidoni, L., Arterburn, J. M., et al. (2000) · PubMed Central · Cited by 53
Neurotrophic and Neuroprotective Effects of Milk Thistle ( Silybum marianum )on Neurons in Culture
Kittur, S., Wilasrusmee, S., Pedersen, W. A., Mattson, M. P., Straube-West, K., Wilasrusmee, C., Jubelt, B., & Kittur, D. S. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:3:265 · Cited by 53
Involvement of NF-κB and caspases in silibinin-induced apoptosis of endothelial cells
Yoo, H. G., Jung, S. Y., Hwang, Y., Park, J. W., Kim, M. K., Jeong, M., Ahn, S. G., Ahn, B. W., Shin, B. A., Park, R., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.1.81 · Cited by 52
Kang, J. S., Park, S., Yang, K., & Kim, H. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00827-5 · Cited by 50
Pérez-Victoria, J. M., Pérez‐Victoria, F. J., Conseil, G., Maitrejean, M., Comte, G., Barron, D., Pietro, A. D., Castanys, S., & Gamarro, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.439-446.2001 · Cited by 49
Dietzmann, J., Thiel, U., Ansorge, S., Neumann, K. H., & Tüger, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01043-2 · Cited by 47
Mohan, S., Dhanalakshmi, S., Gu, M., Singh, R. P., & Agarwal, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.153 · Cited by 46
Kosina, P., Maurel, P., Jitka Ulrichová, A., & Dvořák, Z. (2005) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20066 · Cited by 39
Thelen, P., Jarry, H., Ringert, R.-H., & Wuttke, W. (2004) · Planta Medica · doi:10.1055/s-2004-818965 · Cited by 38
MAZZIO, E. A., Huber, J., Darling‐Reed, S., Harris, N., & Soliman, K. F. A. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00017-1 · Cited by 38
An adverse reaction to the herbal medication milk thistle (Silybum marianum)
(1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb140322.x · Cited by 32
Vereckei, A., Besch, H. R., & Zipes, D. P. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.02446.x · Cited by 12
Cited by
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Federico, A., Dallio, M., & Loguercio, C. (2017) · Molecules · doi:10.3390/molecules22020191 · Cited by 492
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Gillessen, A., & Schmidt, H. H.-J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01251-y · Cited by 490
Bijak, M. (2017) · Molecules · doi:10.3390/molecules22111942 · Cited by 414
New insights into antioxidant strategies against paraquat toxicity
Blanco-Ayala, T., Andérica-Romero, A. C., & Pedraza-Chaverri, J. (2014) · Free Radical Research · doi:10.3109/10715762.2014.899694 · Cited by 256
Cicero, A. F. G., & Colletti, A. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.10.011 · Cited by 70
Metadata
- Authors
- Křen, V., & Walterová, D.
- Venue
- Biomedical Papers
- Publisher
- Palacky University Olomouc
- Published
- 2005-07-01
- Volume
- 149
- Issue
- 1
- Pages
- 29-41
- ISSN
- 1213-8118 (ISSN-L)
- 1804-7521
- OpenAlex
- W2168162647
- Cited by
- 446
- References
- 93
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.